Goblet cells are abundant throughout the gastrointestinal tract and appear to secrete products which form a continuous viscoelastic coat on the mucosal surface of the gastrointestinal tract. In the past, large, densely glycosylated mucin glycoproteins have been the only recognized major secretory product of goblet cells. Recently, the trefoil peptides, a family of structurally distinct small peptides specifically expressed in a regionalize fashion at all levels of the gastrointestinal tract, have been identified as a previously unappreciated major product of goblet onto the mucosal surface where they retain biological activity due to intrinsic resistance to intraluminal degradation. Preliminary studies indicate that trefoil factors form critical constituents at the mucosal- lumenal interface contributing to preservation of mucosal integrity, and protecting against a variety of noxious insults in in vitro model systems. However, there is little insight into the molecular basis of their specific expression in a cell-and tissue-specific manner and the dimensions of their functional activity in sustaining epithelial integrity. The main goals of the studies in this proposal are the elucidation of the features of the genes encoding the trefoil factors and characterization of their protein products in order to both define the molecular basis of goblet cell specific gene expression and to delineate the role of these abundant peptides in sustaining mucosal integrity and function. These goals will be pursued through comprehensive study of the rat and human intestinal trefoil factors (RITF and HITF), identified and cloned in this laboratory which are present in high concentrations in goblet cells throughout the small and large intestinal epithelium. Two major specific aims are planned: (I) Identification of genetic elements responsible for the highly specific expression of ITF in intestinal and colonic goblet cells as well as genetic elements contributing to functional modulation of ITF expression. The latter will be facilitated through the combined application of transient transfection and transgenic techniques and the study of ITF expression in established cell lines. (II) The functional characterization of the biological activities of ITF and other trefoil peptides obtained by direct purification and expression cloning through assessment of their effects on injury of rat and human intestinal and colonic cell lines, and mucosal explants in vitro. Collectively, these studies should provide insights into the trefoil family of proteins and a newly recognized dimension of mucosal biology as well as fundamental insights into the molecular basis of intestinal and goblet cell function. These insights promise to yield new perspective on mechanisms of mucosal destruction, repair and function in inflammatory bowel disease and other forms of injury in the gastrointestinal tract.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046906-06
Application #
2905566
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1994-05-01
Project End
2002-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Paulsen, Friedrich P; Woon, Chee-Wai; Varoga, Deike et al. (2008) Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds. J Biol Chem 283:13418-27
Kalabis, Jiri; Rosenberg, Ian; Podolsky, Daniel K (2006) Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J Biol Chem 281:6434-41
Beck, P L; Wong, J F; Li, Y et al. (2004) Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126:796-808
Fernandez-Estivariz, Concepcion; Gu, Li H; Gu, Liang et al. (2003) Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding. Am J Physiol Regul Integr Comp Physiol 284:R564-73
Iwakiri, D; Podolsky, D K (2001) A silencer inhibitor confers specific expression of intestinal trefoil factor in gobletlike cell lines. Am J Physiol Gastrointest Liver Physiol 280:G1114-23
Andoh, A; Kinoshita, K; Rosenberg, I et al. (2001) Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol 167:3887-93
Iwakiri, D; Podolsky, D K (2001) Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology 120:1372-80
Taupin, D R; Kinoshita, K; Podolsky, D K (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 97:799-804
Podolsky, D K (2000) Review article: healing after inflammatory injury--coordination of a regulatory peptide network. Aliment Pharmacol Ther 14 Suppl 1:87-93
Kinoshita, K; Taupin, D R; Itoh, H et al. (2000) Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680-90

Showing the most recent 10 out of 24 publications